{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:24:00Z","timestamp":1784755440169,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.intimp.2023.110707","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:29:03Z","timestamp":1690324143000},"page":"110707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19"],"prefix":"10.1016","volume":"123","author":[{"given":"Mahsa","family":"Khoramipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-5789","authenticated-orcid":false,"given":"Amir","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hadi Abbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2023.110707_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"NEJM"},{"issue":"8","key":"10.1016\/j.intimp.2023.110707_b0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China - key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.intimp.2023.110707_b0015","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"NEJM"},{"key":"10.1016\/j.intimp.2023.110707_b0020","first-page":"1","article-title":"Mortality rate of patients with COVID-19 based on underlying health conditions","author":"Choi","year":"2021","journal-title":"Disaster Med. Public Health Prep."},{"key":"10.1016\/j.intimp.2023.110707_b0025","doi-asserted-by":"crossref","unstructured":"C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 395 (2020) 497\u2013506, 10.1016\/S0140-6736(20)30183-5.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.1016\/j.intimp.2023.110707_b0030","doi-asserted-by":"crossref","unstructured":"M. Gholami, F. Sakhaee, F. Mirzaei Gheinari, F. Sotoodehnejadnematalahi, M. Ghazanfari Jajin, M.S. Zamani, et al., Interferon-Induced Transmembrane Protein 3 rs34481144 C\/T Genotype and Clinical Parameters Related to Progression of COVID-19, J. Immunol. Res. 7 (2023) 2345062, 10.1155\/2023\/2345062.","DOI":"10.1155\/2023\/2345062"},{"key":"10.1016\/j.intimp.2023.110707_b0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41588-021-00854-7","article-title":"Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity","volume":"53","author":"Shelton","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2023.110707_b0040","doi-asserted-by":"crossref","unstructured":"I. Andolfo, R. Russo, V. A. Lasorsa, S. Cantalupo, B. E. Rosato, F. Bonfiglio, et al., Common Variants at 21q22.3 Locus Influence MX1 and TMPRSS2 Gene Expression and Susceptibility to Severe COVID-19, iScience 24 (2021) 102322, 10.1016\/j.isci.2021.102322.","DOI":"10.1016\/j.isci.2021.102322"},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0045","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1038\/s41598-023-30859-7","article-title":"Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants","volume":"13","author":"Al-Gharrawi","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12985-021-01692-z","article-title":"The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients","volume":"18","author":"Rahimi","year":"2021","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.intimp.2023.110707_b0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.arcmed.2023.03.006","article-title":"Role of FokI rs2228570 and Tru9I rs757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2","volume":"54","author":"Shawi","year":"2023","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40246-023-00468-6","article-title":"Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants","volume":"17","author":"Abbood","year":"2023","journal-title":"Hum. Genomics."},{"key":"10.1016\/j.intimp.2023.110707_b0065","article-title":"A Year of COVID-19 GWAS results from the GRASP Portal reveals potential genetic risk factors","volume":"3","author":"Thibord","year":"2022","journal-title":"Hum. Genet. Genomics Adv."},{"key":"10.1016\/j.intimp.2023.110707_b0070","article-title":"ABO rs657152 and blood groups are as predictor factors of COVID-19 mortality in the Iranian population","volume":"5988976","author":"Mirzaei Gheinari","year":"2022","journal-title":"Dis. Markers."},{"key":"10.1016\/j.intimp.2023.110707_b0075","unstructured":"COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19, Nature 608(7921) (2022) E1\u2013E10, 10.1038\/s41586-022-04826-7."},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-023-00501-8","article-title":"The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants","volume":"17","author":"Sheikhian","year":"2023","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.intimp.2023.110707_b0085","doi-asserted-by":"crossref","unstructured":"A.P. Khawaja, A.N .Warwick, P.G. Hysi, A. Kastner, A. Dick, P.T. Khaw, et al., Associations With Covid-19 Hospitalisation Amongst 406,793 Adults: The UK Biobank Prospective Cohort Study, medRxiv (2020), 10.1101\/2020.05.06.20092957.","DOI":"10.1101\/2020.05.06.20092957"},{"issue":"3","key":"10.1016\/j.intimp.2023.110707_b0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/all.14675","article-title":"Association between asthma and clinical mortality\/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention","volume":"76","author":"Choi","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.intimp.2023.110707_b0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.14480","article-title":"COVID-19 and asthma, the good or the bad?","volume":"76","author":"Wang","year":"2021","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.intimp.2023.110707_b0100","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/all.14420","article-title":"Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19","volume":"75","author":"Avdeev","year":"2020","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.intimp.2023.110707_b0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.anai.2021.02.023","article-title":"The evidence is in that asthma is not associated with severe coronavirus disease 2019","volume":"126","author":"Timberlake","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.intimp.2023.110707_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112970","article-title":"Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease","volume":"150","author":"de Seabra Rodrigues","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2023.110707_b0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaci.2006.12.665","article-title":"Increased expression of ADAM33 and ADAM8 with disease progression in asthma","volume":"119","author":"Foley","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110707_b0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0091-6749(03)01939-0","article-title":"Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations","volume":"112","author":"Howard","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110707_b0125","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1164\/rccm.200409-1251OC","article-title":"ADAM33 expression in asthmatic airways and human embryonic lungs","volume":"171","author":"Haitchi","year":"2005","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"10.1016\/j.intimp.2023.110707_b0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/thx.2004.027227","article-title":"Contribution of ADAM33 polymorphisms to the population risk of asthma","volume":"60","author":"Blakey","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2023.110707_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pupt.2005.02.008","article-title":"ADAM33: a newly identified protease involved in airway remodeling","volume":"19","author":"Holgate","year":"2006","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.110707_b0140","first-page":"447","article-title":"Unravelling the role of ADAM 33 in asthma","volume":"137","author":"Mahesh","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.intimp.2023.110707_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00281-003-0153-z","article-title":"The role of ADAM33 in the pathogenesis of asthma, Springer","volume":"25","author":"Cakebread","year":"2004","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2023.110707_b0150","first-page":"507","article-title":"Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls","volume":"137","author":"Tripathi","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.intimp.2023.110707_b0155","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature06014","article-title":"Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma","volume":"448","author":"Moffatt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110707_b0160","doi-asserted-by":"crossref","unstructured":"S. Cho, C.J. Wu, T. Yasuda, L. Cruz, A.A. Khan, L.L.i Lin, et al., miR-23 approximately 27 approximately 24 clusters control effector T cell differentiation and function, J. Exp. Med. 213 (2016) 235\u2013249, 10.1084\/jem.20150990.","DOI":"10.1084\/jem.20150990"},{"issue":"2","key":"10.1016\/j.intimp.2023.110707_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MCO.0000000000000349","article-title":"Sphingolipids, ORMDL3 and asthma: what is the evidence?","volume":"20","author":"Worgall","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.intimp.2023.110707_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/572025","article-title":"ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma","volume":"2014","author":"Tripathi","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2023.110707_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/pr.2013.186","article-title":"17q21 locus and ORMDL3: an increased risk for childhood asthma","volume":"75","author":"Ono","year":"2014","journal-title":"Pediatr Res."},{"key":"10.1016\/j.intimp.2023.110707_b0180","doi-asserted-by":"crossref","unstructured":"M.J. Kang, H.S. Yu, J.H. Seo, H.Y. Kim, Y.H. Jung, Y.J. Kim, et al., GSDMB\/ORMDL3 variants contribute to asthma susceptibility and eosinophil-mediated bronchial hyperresponsiveness. Hum Immunol, 73(9) (2012) 954-9, https:\/\/doi:10.1016\/j.humimm.2012.06.009.","DOI":"10.1016\/j.humimm.2012.06.009"},{"key":"10.1016\/j.intimp.2023.110707_b0185","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1093\/nar\/gkg526","article-title":"NEBcutter: a program to cleave DNA with restriction enzymes","volume":"31","author":"Vincze","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2023.110707_b0190","unstructured":"R.A. McPherson, M.R. Pincus, \u201cHenry's Clinical Diagnosis and Management by Laboratory Methods, 24th ed\u201d (2021), Faculty Bookshelf, Elsevier, https:\/\/hsrc.himmelfarb.gwu.edu\/books\/268."},{"key":"10.1016\/j.intimp.2023.110707_b0195","doi-asserted-by":"crossref","unstructured":"C. Wang, R. Deng, L. Gou, Z. Fu, X. Zhang, F. Shao, et al., Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters, Ann. Transl. Med. 8 (9) (2020) 593, 10.21037\/atm-20-3391.","DOI":"10.21037\/atm-20-3391"},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3892\/mmr.2021.12141","article-title":"Silencing a disintegrin and metalloproteinase\u201333 attenuates the proliferation of vascular smooth muscle cells via PI3K\/AKT pathway: Implications in the pathogenesis of airway vascular remodeling","volume":"24","author":"Yan","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2023.110707_b0205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.110707_b0210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/all.14465","article-title":"The role of peripheral blood eosinophil counts in COVID-19 patients","volume":"76","author":"Xie","year":"2020","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.intimp.2023.110707_b0215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan","volume":"323","author":"Wang","year":"2020","journal-title":"China, JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2023.110707_b0220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jinf.2019.02.006","article-title":"The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis","volume":"78","author":"Russell","year":"2019","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2023.110707_b0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajem.2020.12.003","article-title":"Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality","volume":"40","author":"Vafadar Moradi","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2023.110707_b0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajem.2020.11.058","article-title":"Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19","volume":"40","author":"Seyit","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110707_b0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2023.110707_b0240","first-page":"46","article-title":"Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality","volume":"20","author":"Ghazanfari","year":"2021","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110707_b0245","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","article-title":"Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection","volume":"52","author":"Henry","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.intimp.2023.110707_b0250","doi-asserted-by":"crossref","unstructured":"D. Wang, R. Li, J. Wang, Q. Jiang, C. Gao, J. Yang, et al., Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infect. Dis. 20 (2020) 519, 10.1186\/ s12879-020-05242-w.","DOI":"10.1186\/s12879-020-05242-w"},{"issue":"7","key":"10.1016\/j.intimp.2023.110707_b0255","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical Features of COVID-19-Related Liver Functional Abnormality","volume":"18","author":"Fan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110707_b0260","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jmv.26097","article-title":"Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19","volume":"92","author":"Ali","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2023.110707_b0265","doi-asserted-by":"crossref","unstructured":"I. Huang, R. Pranata, M.A. Lim, A. Oehadian, B. Alisjahbana, C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis, Ther. Adv. Respir. Dis. (2020) 14 1753466620937175, 10.1177\/1753466620937175.","DOI":"10.1177\/1753466620937175"},{"key":"10.1016\/j.intimp.2023.110707_b0270","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive Protein at Sites of Inflammation and Infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110707_b0275","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/bjh.16725","article-title":"Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"189","author":"Xiong","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110707_b0280","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923010329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:30:28Z","timestamp":1736433028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923010329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":56,"alternative-id":["S1567576923010329"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110707","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the association between clinical parameters and ADAM33 and ORMDL3 asthma gene single-nucleotide polymorphisms with the severity of COVID-19","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110707"}}